Clinical trials
Terminated Prostatic Neoplasms, Castration-Resistant trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nuvation Bio Inc. | 2 |
| Bayer | 1 |
| Bristol-Myers Squibb | 1 |
| MacroGenics | 1 |
| Poseida Therapeutics, Inc. | 1 |
| SpectronRX | 1 |
| Veru Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms, Castration-Resistant | 8 |
| Prostatic Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Neoplasm Metastasis | 2 |
| Anus Neoplasms | 1 |
| Carcinoma, Acinar Cell | 1 |
| Carcinoma, Adenoid Cystic | 1 |
| Carcinoma, Mucoepidermoid | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Carcinoma, Small Cell | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.